Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary May 17, 2022	Evoke Pharma to Present at H.C. Wainwright Global Investment Conference SOLANA BEACH, Calif. , May 17, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray, today announced that its management team will	View HTML PDF Version
Toggle Summary Nov 25, 2014	Evoke Pharma to Present at LD Micro Conference SOLANA BEACH, Calif. , Nov. 25, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an investor presentation on Thursday, December 4, 2014 at 11:30AM PT at the LD Micro Main Event VII	View HTML Evoke Pharma to Present at LD Micro Conference 15.5 KB
Toggle Summary Sep 06, 2016	Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference SOLANA BEACH, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave Gonyer, R.Ph., President and CEO will be presenting at the Rodman & Renshaw 18 th Annual	View HTML Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference 12.3 KB
Toggle Summary Sep 05, 2017	Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference SOLANA BEACH, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it will be featured as a presenting company at the 19th Annual Rodman & Renshaw Global	View HTML Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference 17.9 KB
Toggle Summary Mar 04, 2015	Evoke Pharma to Present at the 27th Annual ROTH Conference SOLANA BEACH, Calif. , March 4, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an investor presentation on Wednesday, March 11, 2015 at 10:00AM PT at the 27 th Annual ROTH Conference .	View HTML Evoke Pharma to Present at the 27th Annual ROTH Conference 25.4 KB
Toggle Summary Sep 04, 2014	Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference SOLANA BEACH, Calif. , Sept. 4, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave Gonyer , CEO, will present a corporate overview at the Aegis Capital Corp.	View HTML Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference 15.2 KB
Toggle Summary Mar 06, 2018	Evoke Pharma to Present at the Upcoming Roth and Oppenheimer Investor Conferences SOLANA BEACH, Calif. , March 06, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that Dave Gonyer , President and Chief Executive Officer, will present at the 30 th Annual Roth	View HTML PDF Version
Toggle Summary Feb 17, 2016	Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 Clinical Data Support Cardiac Safety of EVK-001	View HTML Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 16.2 KB
Toggle Summary May 05, 2021	Evoke Pharma to Report First Quarter 2021 Financial Results on May 12, 2021 SOLANA BEACH, Calif. , May 05, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its first quarter 2021 financial results on	View HTML PDF Version
Toggle Summary May 03, 2022	Evoke Pharma to Report First Quarter 2022 Financial Results on May 10, 2022 SOLANA BEACH, Calif. , May 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma , Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its first quarter 2022 financial results on Tuesday, May	View HTML PDF Version